STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocu... (m has engineeredchanges to the current l...)

HOME >> MEDICINE >> NEWS

STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses

Date:11/20/2008

m has engineered changes to the current lens to maximize the current levels of accommodation. During Phase Two CAST will evaluate these design changes against the baseline accommodative data collected from Phase One. The Company does not currently believe that these changes would require supplemental premarket approval from the FDA, which means the redesigned lens could be available during 2009. Once data is completed the Company will decide whether to apply for an accommodative labeling claim from the FDA. Phase Three will involve a newly designed Collamer Lens which would require a full clinical study and submission to the FDA for approval to commercialize the device and make accommodative claims in the U.S.

Visian ICL Highlighted on CBS produced show, "The Doctors"

STAAR also uses the Collamer material in the Visian ICL, a product that provides an alternative to LASIK for refractive patients. Dr. Paul Dougherty, who is a member of CAST, appeared on the November 14th airing of a nationally syndicated show, "The Doctors." On the program Dr. Dougherty was confronted with a patient who had worn glasses since the age of six and had been told by other ophthalmologists that LASIK was not an option. The Visian ICL procedure was performed and the patient was able to see 20/15 or better immediately. The patient reported that she could see "better than ever in her entire life." Dr. Dougherty referred to the Visian ICL procedure as providing HD Vision or High Quality Vision. The day the segment aired the number of visitors to the Visian ICL website increased by tenfold. The segment can be viewed by visiting: www.visianinfo.com and clicking on media coverage.

Collamer is a proprietary collagen copolymer material developed by STAAR. Its name derives from the material's composition; it is a 100 percent pure collagen copolymer. Collamer is composed of a
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. STAAR Surgical Reports Operational Progress
2. STAAR Surgical Announces Third Quarter 2007 Earnings Release Date and Conference Call
3. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
4. STAAR Surgical Reports Third Quarter Results
5. Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical
6. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
7. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
8. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
9. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
10. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
11. STAAR Surgical Reports Fourth Quarter and Year End Results

Post Your Comments:

STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocu...(m has engineeredchanges to the current l...),Health